Research and Development

Bioscience leaders from both sides of the Atlantic have joined in a war game that could help boost the UK …

MedImmune, AstraZeneca's biotech arm, has opened a new R&D facility in Cambridge as part of a major expansion of its …

The government is investing £5 million in specialist research projects on the planning and provision of health services. The new …

Contract research organisations are now play a key role in the development of most of the industry's drugs, with some …

Oxford BioMedica has settled on a permanent chief executive, promoting John Dawson from his acting leadership position. Chairman professor Alan …

How did you get into your current role After completing my D.Phil at Oxford, I looked for an opportunity in …

AstraZeneca's head of global drug discovery Jan Lundberg says his younger years as a sportsman have made him a determined …

Roche is to develop a potential cancer therapy with two business partners. Genentech, the Swiss biotech company GlycArt – wholly-owned …

GlaxoSmithKline is set to cut about 850 jobs in early-stage research and development at sites across the world, including the …

 The wisdom that emerging markets are vital to the pharmaceutical and biotechnology industry’s future has become a lot more conventional …

Europe’s biotech sector is being hit hard by the credit crunch, with small and medium-sized companies being starved of funding …

NICE's rejection of four new cancer drugs predictably provoked the ire of campaigners, again raising unfavourable comparisons with European uptake …

 GSK has unveiled a new integrated oncology R&D unit aimed at enhancing its presence in cancer care.The unit will be …